EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/115557
4
March 2013
EW NEWS & OPINION
OIS gears up for second
year at ASCRS meeting
by Ellen Stodola EyeWorld Staff Writer
T
his year's Ophthalmology
Innovation Summit (OIS)
at ASCRS (OIS@ASCRS)
will be held in San Francisco on Thursday, April
18. It will be the second anniversary
of the event at ASCRS, which aims
to bring together those from the
clinical, technological, and business
sides of ophthalmology. Attendees
are expected to range from industry
representatives in both public and
private companies to surgeons to
innovators and entrepreneurs.
2ND ANNUAL
ANNUAL
APRIL 18, 2013
18, 2013
The Westin, San Francisco Market Street
Westin,
Francisco Market Street
OIS@ASCRS will unite thought leaders in anterior segment with a focus on facilitating
ophthalmic surgical innovation, create an ecosystem of clinical, technology and business.
ϮϬϭϮK/^Λ^Z^ƩĞŶĚĞĞĞŵŽŐƌĂƉŚŝĐƐ
ϮϱϬнĞůĞŐĂƚĞƐĨƌŽŵϯϬ^ƚĂƚĞƐĂŶĚϭϳĐŽƵŶƚƌŝĞƐƌĞƉƌĞƐĞŶƚĞĚƚŚĞĨŽůůŽǁŝŶŐĐĂƚĞŐŽƌŝĞƐ
Summit Chairman:
Chairman:
Summit Co-Chairs:
Co-Chairs:
Emmett Cunningham, Jr., MD, PhD, MPH
Jr.,
Partner
Partner
Clarus Ventures
Clarus Ventures
Gilbert Kliman, MD
Gilbert Kliman,
Managing Director
Managing Director
InterWest Partners
InterWest Partners
William Link,
William J. Link, PhD
Managing Director
Managing Director
Versant Ventures
Versant Ventures
Advisory Board Members:
Advisory Board Members:
Anthony P. Adamis,
Anthony P. Adamis, MD
VP, Global Head of
VP, Global Head
P
Ophthalmology
Ophthalmology
Genentech
Genentech
Mark Blumenkranz, MD
Mark Blumenkranz,
Professor & Chairman,
Professor Chairman,
Department of
Department
Ophthalmology
Ophthalmology
Stanford University
Stanford University
Andy Corley
Andy Corley
Principal
Principal
Yelroc Consulting
Yelroc
Tom
Tom Dunlap
President and
President and CEO
HOYA Surgical
HOYA Surgical Optics
Malvina Eydelman,
Malvina B. Eydelman, MD
Director, FDA
Director, FDA
r
Division of Ophthalmic,
Ophthalmic,
Neurologic and Ear, Nose
Neurologic and Ear, Nose
and Throat Devices
and Throat Devices
David Guyer,
David Guyer, MD
r
Partner
Partner
SV Life
SV Life Sciences
Charline
Charline Gauthier OD, PhD
Executive-in-Residence
Executive-in-Residence
InterWest Partners
InterWest Partners
Eugene DeJuan, MD
DeJuan,
Partner
Partner
OneFocus Ventures
OneFocus Ventures
Professor,
Professor, UCSF
,
David A. Karcher
David A. Karcher
Executive Director
Executive Director
ASCRS
Michael Kaschke, MD
Michael Kaschke,
President & CEO
President
Carll Zeiss AG
Car
AG
Richard Lindstrom, MD
Richard Lindstrom,
Founder &
Founder
Attending Surgeon
Attending Surgeon
Minnesota Eye Consultants
Minnesota Eye Consultants
K. Angela Macfarlane
Macfarlane
President
President & CEO
ForSight Labs
ForSight Labs
Sabri Markabi, MD
Sabri Markabi,
;`a]^E]\a[YdG^Ú[]j
;`a]^E]\a[YdG^Ú[]j
Sr. VP R&D
Sr.
Alcon Laboratories, Inc.
Laboratories,
Mazzo
Jim Mazzo
President, (Retired),
President, (Retired),
Abbott Medica
Abbott Medicall Optics Inc.
Sr. VP, Abbott Laboratories
Sr. VP, Abbott Laboratories
P
David W. Parke II, MD
David W. Parke
Executive VP, CEO
P
Executive VP,
American Academy of
American Academy
Ophthalmology
Ophthalmology
Samir Patel, MD
Patel,
President & CEO
President
Ophthotech Corporation
Ophthotech Corporation
Calvin Roberts, MD
Calvin Roberts,
Executive VP, CMO
Executive VP,
P
Bausch
Bausch and Lomb
Ellen Strahlman, MD, MHSc
Strahlman,
Kj&NH$G^Ú[]g^l`];=G
Kj&NH$G^Ú[]g^l`];=G
GlaxoSmithKline
GlaxoSmithKline
Scott
Murthy V. Simhambhatla,
Murthy V. Simhambhatla, PhD Scott M. Whitcup, MD
EVP,
P
and
President, Abbott Medical
President, Abbott Medical Optics EVP, R&D and CSO
Allergan, Inc.
Allergan,
Vice President, Abbott
Senior Vice President, Abbott
Laboratories
Laboratories
"
"I only attend events that provide the most
only attend events
provide most
[gehj]`]fkan]]\m[Ylagfafl`]egkl]^Ú[a]fl
[gehj]`]fkan]]\m[Ylagfafl`]egkl]^Ú[a]fl
manner. OIS is that meeting. The intersection
manner.
intersection
g^[dafa[Yd$ÚfYf[aYdYf\[gehYfqh]jkh][lan]kafYgf]\Yq^gjme
g^[dafa[Yd$ÚfYf[aYdYf\[gehYfqh]jkh][lan]kafYgf]\Yq^gjme
enables myself and team to stay current and add value to
enables myself and our team to stay current and add value to our
business partners
business partners in the ophthalmology space."
ophthalmology space."
--Evan Norton, Director, Abbott Ventures
--Evan M Norton, Director, Abbott Ventures
r
"
Hj]k]flaf_JNGkl][`fgdg_qYlGAK`YkYlljY[l]\Ydglg^afl]j]kl
Hj]k]flaf_JNGkl][`fgdg_qYlGAK`YkYlljY[l]\Ydglg^afl]j]kl
from investors, clinicians, and strategic companies. Everyone
from investors,
and strategic companies. Everyone
leaves OIS with a better vision of the future of the ophthalmic
leaves
better
future
ophthalmic
industry."
industry."
--Randy Alexander, Chairman, ReVision Optics
--Randy Alexander, Chairman, ReVision
George D. Yancopoulosw MD, PhD
George Yancopoulosw
Executive VP,
P
Executive VP, CSO and President
President
Regeneron Laboratories
Regeneron Laboratories
"
gives industry forum to interact
"OIS gives industry a forum to interact in a meaningful
meaningful
way
and private companies which results
way with clinicians and private companies which results in
excellent synergy. came away
excellent synergy. I came away with a deeper understanding
deeper understanding
how industry help."
of how industry can help."
%%%Bgk]h`EYjcg^^$E<$H`<$?dgZYd